Intl Society Of Pharmacoeconomics And Outcomes Research Inc
- Assets
- $26.3m
- Revenue
- $14.2m
- Investments
- $0.0
- Employees
- 57
- Location
- Lawrenceville, NJ
- Founding
- 10/1995
- Data as of
- 12/2020
- EIN
- 22-3369741
Organization Overview
Intl Society Of Pharmacoeconomics And Outcomes Research Inc is located in Lawrenceville, NJ. The organization was established in 1995. According to its NTEE Classification (H02) the organization is classified as: Management & Technical Assistance, under the broad grouping of Medical Research and related organizations. As of 12/2021, Intl Society Of Pharmacoeconomics And Outcomes Research Inc employed 57 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Intl Society Of Pharmacoeconomics And Outcomes Research Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2020, Intl Society Of Pharmacoeconomics And Outcomes Research Inc generated $14.2m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 4.0% each year. All expenses for the organization totaled $9.4m during the year ending 12/2020. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
PROMOTE GLOBAL HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING
Describe the Organization's Program Activity:
Part 3 - Line 4a
ISPOR IS A NON-PROFIT GLOBAL SCIENTIFIC AND EDUCATIONAL ORGANIZATION WITH APPROXIMATELY 4,949 MEMBERS, WHO ARE INVOLVED IN HEALTHCARE OUTCOMES RESEARCH (INCLUDING CLINICAL, ECONOMIC AND PATIENT-REPORTED OUTCOMES) OF HEALTH TECHNOLOGIES (DRUGS, DEVICES, DIAGNOSTICS) AND SERVICES OR THE USE OF OUTCOMES RESEARCH IN HEALTHCARE DECISIONS. THE MISSION OF ISPOR IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. ISPOR IS FUNDED THROUGH ITS MEETINGS, TRAINING COURSES AND MEMBERSHIP DUES. THROUGH ITS MULTIPLE MEETINGS EACH YEAR, ISPOR PROVIDES A FORUM TO FACILITATE THE INTERCHANGE OF SCIENTIFIC KNOWLEDGE IN PHARMACOECONOMICS /HEALTH ECONOMICS AND OUTCOMES RESEARCH, HEALTH POLICY AND THE USE OF THIS RESEARCH IN HEALTHCARE DECISIONS.ISPOR PUBLISHES TWO SCIENTIFIC JOURNALS, ONE TECHNICAL AND NEWS JOURNAL, AND FOUR ELECTRONIC NEWSLETTERS. ISPOR DEVELOPS CONSENSUS DOCUMENTS (GOOD PRACTICES/GUIDELINES) ON OUTCOMES RESEARCH METHODS OR USE OF THIS RESEARCH IN HEALTHCARE DECISIONS. ISPOR FOSTERS EDUCATION AND THE DEVELOPMENT OF OUTCOMES RESEARCH AT THE LOCAL LEVEL WITH ITS REGIONAL CHAPTERS AND STUDENT CHAPTERS GLOBALLY TO PROMOTE THE SCIENCE OF PHARMACOECONOMICS/HEALTH ECONOMICS AND HEALTH OUTCOMES RESEARCH WORLDWIDE. IN 2021 ISPOR HELD THREE VIRTUAL CONFERENCES (NORTH AMERICAN, EUROPEAN, AND LATIN AMERICA) INCLUDING 3,000 SCIENTIFIC PRESENTATIONS. IN 2021, ISPOR PUBLISHED 2,745 PAGES OF OUTCOMES RESEARCH AND HEALTH POLICY PAPERS IN ITS THREE JOURNALS: VALUE IN HEALTH, VALUE IN HEALTH REGIONAL ISSUES AND VALUE AND OUTCOMES SPOTLIGHT. IN 2021 ISPOR HAD OVER 4,949 MEMBERS FROM 102 COUNTRIES, 144 STUDENT CHAPTERS AND OVER 86 REGIONAL CHAPTERS AROUND THE WORLD. THROUGH ISPOR TASK FORCES, COUNCILS AND SPECIAL INTEREST GROUPS, ISPOR HAS DEVELOPED 'TOOLS' FOR OUTCOMES RESEARCHERS, SUCH AS GOOD PRACTICES FOR OUTCOMES RESEARCH WITH OVER 1,000,000 DOWNLOADS ANNUALLY AND A WEB-BASED DATABASE OF OVER 56,000 RESEARCH PRESENTATIONS GIVEN AT ISPOR MEETINGS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Nancy S Berg CEO & Executive Director | OfficerTrustee | 40 | $619,415 |
Susan Capon Chief Operating Officer | Officer | 40 | $239,975 |
Elizabeth Lane Chief Marketing Officer | 40 | $171,497 | |
Julie Mcgrath Senior Director, Global Events | 40 | $170,929 | |
Paul Wong Director, Global Events | 40 | $164,800 | |
Kevin Dolan Director, Finance (until Sept) | Officer | 40 | $161,048 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Stellaliance Scientific Consulting | 12/30/21 | $233,200 |
Horizon Blue Cross Employee Medical Insurance | 12/30/21 | $442,644 |
Matrix Group International Marketing Consultancy Services | 12/30/21 | $139,935 |
Elsevier Inc Publishing | 12/30/21 | $201,489 |
Richard J Wilke Scientific Consulting | 12/30/21 | $320,000 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $105,000 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $105,000 |
| Total Program Service Revenue | $4,613,194 |
| Investment income | $322,828 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $55,029 |
| Net Gain/Loss on Asset Sales | -$176,842 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $14,162,413 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,121,673 |
| Compensation of current officers, directors, key employees. | $716,215 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $3,803,242 |
| Pension plan accruals and contributions | $252,387 |
| Other employee benefits | $494,997 |
| Payroll taxes | $342,487 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $22,807 |
| Fees for services: Accounting | $31,463 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $97,484 |
| Fees for services: Other | $717,098 |
| Advertising and promotion | $0 |
| Office expenses | $385,003 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $75,457 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $390,386 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $233,596 |
| Insurance | $41,696 |
| All other expenses | $156,954 |
| Total functional expenses | $9,413,154 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,430,993 |
| Savings and temporary cash investments | $593,941 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $6,944,301 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $490,530 |
| Net Land, buildings, and equipment | $3,161,257 |
| Investments—publicly traded securities | $13,657,167 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $26,278,189 |
| Accounts payable and accrued expenses | $371,900 |
| Grants payable | $0 |
| Deferred revenue | $1,213,686 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $1,015,900 |
| Other liabilities | $7,391 |
| Total liabilities | $2,608,877 |
| Net assets without donor restrictions | $23,669,312 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $26,278,189 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that Intl Society Of Pharmacoeconomics And Outcomes Research Inc has recieved totaling $30,000.
| Awarding Organization | Amount |
|---|---|
Pharmaceutical Research And Manufacturers Of America Washington, DC PURPOSE: GENERAL CONTRIBUTION | $30,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
The National Hemophilia Foundation New York, NY | $46,786,068 | $26,439,522 |
Winifred Masterson Burke Medical Research White Plains, NY | $9,563,124 | $17,375,898 |
Lankenau Institute For Medical Research Wynnewood, PA | $8,021,343 | $9,109,367 |
Tri-Institutional Therapeutics Discovery Institute Inc New York, NY | $5,819,394 | $16,905,997 |
American College Of Gastroenterology Inc Bethesda, MD | $294,139,585 | $33,197,457 |
Community Partners In Action Inc Hartford, CT | $16,042,672 | $16,238,720 |
South Shore Health Express Inc South Weymouth, MA | $32,089,469 | $12,224,356 |
Zachary And Elizabeth M Fisher Center For Alzheimers Research Fdn New York, NY | $40,802,431 | $10,021,313 |
Baim Institute For Clinical Research Inc Boston, MA | $19,935,879 | $17,724,993 |
Christopher Reeve Foundation A New Jersey Nonprofit Corporation Short Hills, NJ | $8,265,891 | $16,839,665 |
Coalition Of Cancer Cooperative Groups Philadelphia, PA | $21,235,863 | $14,701,631 |
The International Academy Of Hope New York, NY | $21,778,473 | $17,024,094 |